[1]刘占国,程文静,宋国红,等.加味地黄饮子联合西医常规疗法治疗非痴呆型血管性认知功能障碍肾虚痰阻证临床研究[J].中国中医药信息杂志,2021,28(10):116-120.[doi:10.19879/j.cnki.1005-5304.202104580]
 LIU Zhanguo,CHENG Wenjing,SONG Guohong,et al.Clinical Study on Modified Dihuang Yinzi Prescription Combined with Western Routine Medicine Therapy for Treatment of VCIND with Kidney-deficiency and Phlegm-obstruction Syndrome[J].zhongguo zhongyiyao xinxi zazhi,2021,28(10):116-120.[doi:10.19879/j.cnki.1005-5304.202104580]
点击复制

加味地黄饮子联合西医常规疗法治疗非痴呆型血管性认知功能障碍肾虚痰阻证临床研究

参考文献/References:

[1] SHEN X N, LU Y, TAN C, et al. Identification of inflammatory and vascular markers associated with mild cognitive impairment[J]. Aging (Albany NY),2019,11(8):2403-2419.

[2] 付善玉,徐云龙,赵建军.填精益髓解毒法论治血管性认知障碍[J].长春中医药大学学报,2016,32(1):58-60.

[3] 张秀芬,王思梦,白建英,等.经典名方地黄饮子的古代文献考究[J].中国实验方剂学杂志,2020,26(14):59-64.

[4] 谢宁,刘艳丽,宋琳,等.地黄饮子的实验研究进展[J].中华中医药学刊,2015,33(12):2823-2825.

[5] 郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:91-99.

[6] 田金洲,韩明向,涂晋文,等.血管性痴呆的诊断、辨证及疗效判定标准[J].北京中医药大学学报,2000,23(5):16-24.

[7] 中国医师协会神经内科分会认知障碍专业委员会,《中国血管性认知障碍诊治指南》编写组.2019年中国血管性认知障碍诊治指南[J].中华医学杂志,2019,99(35):2737-2744.

[8] NASREDDINE Z S, PHILLIPS N A, BÉDIRIAN V, et al. The Montreal Cognitive Assessment, MoCA:a brief screening tool for mild cognitive impairment[J]. J Am Geriatr Soc,2005,53(4):695-699.

[9] MAIER W, PHILIPP M, GERKEN A. Dimensions of the Hamilton Depression Scale. Factor analysis studies[J]. Eur Arch Psychiatry Neurol Sci,1985,234(6):417-422.

[10] PANTONI L, INZITARI D. Hachinski’s ischemic score and the diagnosis of vascular dementia:a review[J]. Ital J Neurol Sci, 1993,14(7):539-546.

[11] FOLSTEIN M F, FOLSTEIN S E, MCHUGH P R. Mini-mental state:a practical method for grading the cognitive state of patients for the clinician[J]. J Psychiatr Res,1975,12(3):189-198.

[12] 张明园,瞿光亚,金华,等.几种痴呆测试工具的比较[J].中华神经精神科杂志,1991,24(4):194-196.

[13] BLESSED G, TOMLINSON B E, ROTH M. Blessed-Roth dementia scale (DS)[J]. Psychopharmacol Bull,1988,24(4):705-708.

[14] ROCKWOOD K. Vascular cognitive impairment and vascular dementia[J]. J Neurol Sci,2002,203/204:23-27.

[15] GORELICK P B, BOWLER J V. Advances in vascular cognitive impairment[J]. Stroke,2010,41(2):e93-e98.

[16] ZULIANI G, GUERRA G, RANZINI M, et al. High interleukin-6 plasma levels are associated with functional impairment in older patients with vascular dementia[J]. Int J Geriatr Psychiatry, 2007,22(4):305-311.

[17] SUK K, LEE J, HUR J, et al. Activation induced cell death of rat astrocytes[J]. Brain Res,2003,900(2):342-347.

[18] 景光婵,张孟仁.脑内炎性细胞因子与认知功能的关系[J].中国老年学杂志,2013,33(18):4658-4661.

[19] RAPPTER A, BIBER K. Secondary lymphoid tissue chemokine (CCCL21) activates CXCR3 to trigger a C1 current and chemotaxis in murine microglia[J]. J Immunol,2002,168(7):3221-3226.

[20] 宫健伟,叶蕾,张秀丽,等.地黄饮子对脑缺血再灌注模型大鼠血清、脑组织SOD,CAT和GSH-PX及MDA的影响[J].中国实验方剂学杂志, 2013,19(14):247-250.

[21] 宋琳.地黄饮子改善痴呆大鼠学习记忆及其防治AD作用机理的实验研究[D].哈尔滨:黑龙江中医药大学,2005.

[22] 安红梅,史云峰,胡兵,等.熟地黄对D-半乳糖衰老模型大鼠脑衰老的作用研究[J].中药药理与临床,2008,24(3):59-60.

[23] 程小明,曾永青,李惠萍,等.补肾益脑方治疗老年轻度认知障碍的疗效及对血清Ach、SOD、MDA的影响[J].中药材,2014,37(6):1108-1109.

相似文献/References:

[1]周好田,张少春,周福勤.加味地黄饮子合剂辅助氯氮平治疗精神分裂症(紧张型)临床观察[J].中国中医药信息杂志,2006,13(2):60.
 [J].zhongguo zhongyiyao xinxi zazhi,2006,13(10):60.

备注/Memo

基金项目:山东省中医药科技发展计划(2019-0461)

更新日期/Last Update:

2021-09-22